Translational Human Models for Brain PBPK Modelling and CNS Drug Development
Not stated
- Funding
- Funded PhD Project (UK Students Only)
- Application deadline
- 15 October 2026
About the project
About the Project Central nervous system (CNS) drug exposure is difficult to predict because the blood brain barrier (BBB) tightly regulates drug entry via passive permeability and active transporter‑mediated efflux and uptake. Direct measurement of human brain drug concentrations is rarely possible, so there is a need for translational BBB models that generate parameters suitable for physiologically based pharmacokinetic (PBPK) prediction of CNS exposure (1,2). This project will develop a mechanistic, proteomics‑informed in vitro in vivo extrapolation (IVIVE) framework for the human BBB. The student will work with advanced human-relevant BBB models (including human induced pluripotent stem cells (hiPSC)-derived “BBB‑on‑chip” systems) to generate permeability and transporter data for CNS drugs and then use these data to parameterize and refine a PBPK-brain model to predict drug distribution between plasma and key brain compartments (2,3). The project is placed within the Centre for Applied Pharmacokinetic Research (CAPKR), an academically led consortium at the University of Manchester that collaborates closely with industry and regulators. The successful candidate will receive training in BBB in vitro systems, quantitative proteomics and PBPK modelling, providing an excellent platform for a career in model-informed CNS drug development. Entry Requirements: Applicants are expected to hold (or about to obtain) a minimum upper second class undergraduate honours degree (or equivalent) in pharmacy, pharmacology, biomedical sciences, physiology, biomedical engineering or a related discipline. Experience in cell culture, proteomics/transcriptomics and quantitative pharmacokinetics is highly desirable, and prior exposure to blood brain barrier models, transporter biology, or PBPK modelling would be an advantage. For application details, visit the Doctoral Academy website: https://www.bmh.manchester.ac.uk/study/research/apply/ . Candidates must contact the Primary Supervisor before applying to discuss their interest and suitability for the project. Select PhD Pharmacy and Pharmaceutical Sciences on the application form. Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the following link: https://www.bmh.manchester.ac.uk/study/research/getting-started/equality-diversity-inclusion/